A high rate of sleep apnea syndrome (SAS) complicated by atrial fibrillation (AF) has been reported. We reviewed the frequency of SAS complications in AF patients, and reported on the patients for whom SAS was considered to be a cause of the AF. We studied 28 patients with AF who were able to receive a sleep apnea examination. All patients had oxygen saturation measured by an ambulatory percutaneus monitor (PULSOX) during sleep. A sleep apnea examination was performed by polysomnograph (Morpheus) in 19 of the patients. There were 18 patients (64%) with moderate to severe SAS whose apnea hypoxia index (AHI) or 3% oxygen disaturation index was more than 20. In this study, AF was stopped by treating SAS with continuous positive airway pressure (CPAP) or noninvasive positive pressure ventilation (NPPV) in 2 cases. Our study shows a high rate of SAS complications with AF, which is in accord with previous studies. We experienced cases in which AF was stopped by treating SAS with CPAP or NPPV, suggesting it is a cause of AF. (J Arrhythmia 2007; 23: 152-156) 
Introduction
Many cardiovascular diseases are complicated by sleep apnea syndrome (SAS), which is considered to be an aggravating factor. About 60 percent of heart failure patients have SAS, [1] [2] [3] and subjective and objective symptoms of heart failure have been improved by treating SAS with oxygen inhalation therapies. [4] [5] [6] [7] In addition, SAS has attracted attention as a causative disease in hypertensive patients. [8] [9] [10] [11] [12] [13] It has been reported that the rate of SAS complications with atrial fibrillation(AF) is high. 14) We reviewed the frequency of SAS complications in AF patients at our hospital, and report cases in whom SAS is considered to be a cause of AF.
Case Report
We studied 28 patients with chronic atrial fibrillation (Caf) or paroxysmal atrial fibrillation (Paf) who were able to receive a sleep apnea examination in Kouseiren Takaoka Hospital from October, 2004 to January, 2006. Caf is a condition in which AF continues for more than 1 year, and in Paf AF lasts for 24 hours or less. When their medical therapy started, the AF was Caf in 12 patients and Paf in 16 patients. Four Paf patients had their defibrillation treated successfully with antiarrhythmic drugs ( Table 1) . The mean age was 67 AE 11. There were 23 men and 5 women.
All patients had their oxygen saturation measured by an ambulatory percutaneus monitor (PULSOX, TEIJIN PHARMA Ltd.) during sleep. When episodes indicating a 3% oxygen disaturation index (3%ODI) more than 10 times every hour were obtained under close observation during hospitalization, which corresponds to an oxygen saturation dose degradation of more than 3%, a sleep apnea examination was performed using Morpheus (TEI-JIN PHAMA Ltd.). This device is able to measure 6 parameters: nasal air flow, chest and abdominal movements, pulse rate, percutaneus oxygen saturation, and physical position. Using Morpheus, we can distinguish the type of SAS, and measured the apnea hypoxia index (AHI), which is the number of apnea and hypoxia events per hour. Apnea is defined as nasal air-flow arrest for more than 10 seconds, and hypoxia as a reduced nasal air flow with an oxygen disaturation of more than 3%. Nineteen patients were evaluated using Morpheus and 9 patients using only PULSOX. Table 1 shows patient characteristics and outcome for all cases. Among the 9 patients we evaluated only using PLUSOX, there were 7 patients whose 3%ODI was 10 or less, 2 patients above 20, and no patients between 11 and 19. Among the 19 patients evaluated using Morpheus, there were 3 patients whose AHI was below 10, 16 patients more than 20, and no occurred daily. Her AHI was 47, and the type of SAS was obstructive (Figure 1) . In this case, premature atrial contractions (PACs) were observed in hyperventilation, which followed apnea (Figure 2A) , when we reviewed the onset of Paf at the time of sleep apnea, and shifted to Paf ( Figure 2B ). AHI was Figure 4A shows his ECG. His SAS was central and mixed type, and his AHI was 40 (Figure 3) . His AF stopped after starting therapy for SAS with noninvasive positive pressure ventilation (NPPV) on the second day ( Figure 4) . He had maintained sinus rhythm for more than a half year. Hence, when he could not undergo NPPV because of a cold, Af recurred. After resuming NPPV, sinus rhythm returned.
Discussion
In our study, the rate of SAS complication to AF was 64%, which is considerably higher than that in a previous report. 14) We experienced 2 cases whose AF was controlled by treating SAS. In case 1, SAS was regarded as a true cause of AF. In this case, premature atrial contractions (PACs) were observed in hyperventilation, which followed apnea. In a previous study of premature ventricular contraction (PVC) in heart failure patients with Cheyne-Stokes breathing, 15, 16) there were significantly large numbers of PVCs in hyperpnea phases compared to apnea phases. It has been confirmed that sympathetic activity rises in hyperpnea phases following apnea, 17) and elicitation of rising PACs due to sympathetic activity is thought to be one of the causes of Paf in case 1. In addition, we cannot continuously measure blood carbon dioxide pressure and pH, but alternating these parameters under SAS might contribute to Paf. When treating AF with SAS, we experienced successful prevention or termination of AF with CPAP or NPPV, which sufficiently relieved cardiac load, but did not experience a case terminated only by oxygenation.
Conclusions
Our study showed as high a rate of SAS complication with AF as in previous studies. We experienced cases in which AF was stopped by SAS treatment, such as CPAP or NPPV, suggesting it could be considered as being the cause of AF.
